Sökning: onr:"swepub:oai:DiVA.org:uu-361905" >
Prognostic Value of...
-
Rosjo, HelgeAkershus Univ Hosp, Div Med, Sykehusveien 25, N-1478 Lorenskog, Norway;Univ Oslo, Inst Clin Med, Ctr Heart Failure Res, Oslo, Norway
(författare)
Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock : Data From the Albumin Italian Outcome Sepsis Study
- Artikel/kapitelEngelska2018
Förlag, utgivningsår, omfång ...
-
LIPPINCOTT WILLIAMS & WILKINS,2018
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-361905
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-361905URI
-
https://doi.org/10.1097/CCM.0000000000003050DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Objectives: Secretoneurin directly influences cardiomyocyte calcium handling, and circulating secretoneurin levels seem to improve risk prediction in patients with myocardial dysfunction by integrating information on systemic stress, myocardial function, and renal function. Accordingly, in this study, we hypothesized that secretoneurin would improve risk prediction in patients with sepsis and especially in patients with septic shock as these patients are more hemodynamically unstable. Design: Multicenter, interventional randomized clinical trial. Setting: Multicenter, pragmatic, open-label, randomized, prospective clinical trial testing fluid administration with either 20% human albumin and crystalloids or crystalloid solutions alone in patients with severe sepsis or septic shock (The Albumin Italian Outcome Sepsis). Patients or Subjects: In total, 540 patients with septic shock and 418 patients with severe sepsis. Interventions: Either 20% human albumin and crystalloids or crystalloid solutions alone. Measurements and Main Results: We measured secretoneurin on days 1, 2, and 7 after randomization and compared the prognostic value of secretoneurin for ICU and 90-day mortality with established risk indices and cardiac biomarkers in septic shock and severe sepsis. High secretoneurin levels on day 1 were associated with age and serum concentrations of lactate, bilirubin, creatinine, and N-terminal pro-B-type natriuretic peptide. Adjusting for established risk factors and cardiovascular biomarkers, secretoneurin levels on day 1 were associated with ICU (odds ratio, 2.27 [95% CI, 1.05-4.93]; p = 0.04) and 90-day mortality (2.04 [1.02-4.10]; p = 0.04) in patients with septic shock, but not severe sepsis without shock. Secretoneurin levels on day 2 were also associated with ICU (3.11 [1.34-7.20]; p = 0.008) and 90-day mortality (2.69 [1.26-5.78]; p = 0.01) in multivariate regression analyses and improved reclassification in patients with septic shock, as assessed by the net reclassification index. Randomized albumin administration did not influence the associations between secretoneurin and outcomes. Conclusions: Secretoneurin provides early and potent prognostic information in septic patients with cardiovascular instability.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Masson, SergeIRCCS Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy
(författare)
-
Caironi, PietroAzienda Osped Univ S Luigi Gonzaga, Dept Anesthesia & Crit Care, Orbassano, Italy;Univ Torino, Dipartimento Oncol, Turin, Italy
(författare)
-
Stridsberg, MatsUppsala universitet,Biokemisk endokrinologi(Swepub:uu)matsstri
(författare)
-
Magnoli, MichelaIRCCS Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy
(författare)
-
Christensen, GeirInst Expt Med Res, Ulleval, Norway;Univ Oslo, Inst Clin Med, Ctr Heart Failure Res, Oslo, Norway
(författare)
-
Moise, GabriellaOsped Citta Sesto San Giovanni, Dept Anesthesia & Crit Care, Sesto San Giovanni, Italy
(författare)
-
Urbano, Maria CristinaOsped Misericordia, Grosseto, Italy
(författare)
-
Gattinoni, LucianoUniv Gottingen, Dept Anesthesiol Emergency & Intens Care Med, Gottingen, Germany
(författare)
-
Pesenti, AntonioFdn IRCCS Ca Granda Osped Maggiore Policlin, Dipartimento Anestesia, Milan, Italy;Univ Milan, Dipartimento Fisiopatol Med Chirurg & Trapianti, Milan, Italy
(författare)
-
Latini, RobertoIRCCS Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy
(författare)
-
Omland, TorbjornAkershus Univ Hosp, Div Med, Sykehusveien 25, N-1478 Lorenskog, Norway;Univ Oslo, Inst Clin Med, Ctr Heart Failure Res, Oslo, Norway
(författare)
-
Akershus Univ Hosp, Div Med, Sykehusveien 25, N-1478 Lorenskog, Norway;Univ Oslo, Inst Clin Med, Ctr Heart Failure Res, Oslo, NorwayIRCCS Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Critical Care Medicine: LIPPINCOTT WILLIAMS & WILKINS46:5, s. E404-E4100090-34931530-0293
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Rosjo, Helge
-
Masson, Serge
-
Caironi, Pietro
-
Stridsberg, Mats
-
Magnoli, Michela
-
Christensen, Gei ...
-
visa fler...
-
Moise, Gabriella
-
Urbano, Maria Cr ...
-
Gattinoni, Lucia ...
-
Pesenti, Antonio
-
Latini, Roberto
-
Omland, Torbjorn
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Anestesi och int ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Allmänmedicin
- Artiklar i publikationen
-
Critical Care Me ...
- Av lärosätet
-
Uppsala universitet